EWS
ABBV icon

Eagle Wealth Strategies’s AbbVie ABBV Stock Holding History

Eagle Wealth Strategies’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$313K Buy
1,242
+11
+0.9% +$2.37K 0.12% 80
2026
Q1 		$268K Sell
1,231
-83
-6% -$18.4K 0.12% 87
2025
Q4 		$300K Sell
1,314
-40
-3% -$9.11K 0.14% 76
2025
Q3 		$313K Sell
1,354
-287
-17% -$58.4K 0.16% 69
2025
Q2 		$305K Sell
1,641
-117
-7% -$21.7K 0.17% 69
2025
Q1 		$368K Sell
1,758
-115
-6% -$22.4K 0.23% 55
2024
Q4 		$333K Buy
1,873
+3
+0.2% +$552 0.24% 63
2024
Q3 		$369K Buy
1,870
+73
+4% +$13.6K 0.27% 60
2024
Q2 		$308K Sell
1,797
-555
-24% -$91.9K 0.25% 64
2024
Q1 		$425K Sell
2,352
-99
-4% -$17.1K 0.35% 45
2023
Q4 		$380K Buy
+2,451
New +$357K 0.23% 52

Other funds holding ABBV

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Eagle Wealth Strategies's ABBV Position: Q2 2026 in Review

Eagle Wealth Strategies increased its AbbVie (ABBV) stake by 0.89% in Q2 2026, buying an estimated $2.37K and bringing the position to 1,242 shares worth $313K. The position accounts for 0.12% of the portfolio, ranked #80.

Eagle Wealth Strategies first reported a position in ABBV in Q4 2023 and has held it in 11 quarters since. The position peaked at $425K in Q1 2024. 4,190 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • Eagle Wealth Strategies held 1,242 shares of AbbVie worth $313K as of Q2 2026.
  • Eagle Wealth Strategies bought 11 AbbVie shares in Q2 2026, an estimated $2.37K.
  • AbbVie made up 0.12% of Eagle Wealth Strategies's portfolio in Q2 2026, its #80 holding.
  • Eagle Wealth Strategies first reported a position in AbbVie in Q4 2023 and has held it in 11 quarters since.
  • Eagle Wealth Strategies's AbbVie position peaked at $425K in Q1 2024.
  • 4,190 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Eagle Wealth Strategies's 13F filing for Q2 2026, filed 9 Jul 2026.